Gilead Sciences Inc
NASDAQ: GILD
$88.40
-$3.71 (-4.0%)
Closing Price on November 15, 2024
GILD Articles
Stocks opened a bit lower this morning, but almost immediately turned around without being able to break through the opening numbers. Revised third-quarter US GDP numbers were worse than expected,...
Published:
Last Updated:
These are some of Tuesday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls. Amgen Inc. (NASDAQ: AMGN) Cut to Market Perform at BMO. AutoNation Inc. (NYSE:...
Published:
Stock prices plunged this morning and spent most of the day trading way down. The DJIA hovered around -300 points for most of the day, while the NASDAQ was off around -50 points and the S&P 500...
Published:
Last Updated:
Crude oil is at $96.43, down 1.29% Gold is at $1,766, down 0.74%. Hong Kong’s Hang Seng closed down 1.44% to 18,226. Japan’s Nikkei closed lower by 0.32% to 8,348. The U.S. 10-year is at 1.95%,...
Published:
Gilead Sciences Inc. (NASDAQ: GILD) is trading lower on news that it is spending some $11 billion to buy Pharmasset, Inc. (NASDAQ: VRUS). What is interesting is that Pharmasset was valued only at...
Published:
We have compiled a detailed list of expected upside in the biotech sector. The sector has consolidated and now there is about to be a rush of earnings reports from tomorrow’s emerging drug...
Published:
Last Updated:
These are some of this Friday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street research calls. Adtran Inc. (NASDAQ: ADTN) Reiterated Buy and $49 target at...
Published:
Last Updated:
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday morning. AK Steel Holding Corporation (NYSE: AKS) Raised to Buy at Deutsche...
Published:
Last Updated:
The upcoming week is not very active on the earnings front but we do have some key events to watch for individual equities and companies. This our cast of “The Unusual Suspects” for the week...
Published:
Last Updated:
Iron Mountain’s proxy fight with Elliott Management continued, as the company added an Elliott board member and said it may sell its digital assets. Harley fell on weak earnings. Gilead posted...
Published:
Last Updated:
Biotech is becoming the ever-shrinking stock sector. It is almost weekly now that a new biotech acquisition is announced. Big Pharma in the United States and large drugmakers internationally...
Published:
Last Updated:
Investors love huge biotech opportunities for growth. Investors also love to get paid in the form of dividends. Unfortunately, the terms “dividend” and “biotech” never match up. While...
Published:
Last Updated:
2010 is ending and 2011 is about to begin. It has been a very interesting year for major biotech stocks, albeit with lower rewards than seen in 2009 as there have been far fewer ten-baggers with...
Published:
Last Updated:
These are some of this Friday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Airgas Inc. (NYSE: ARG) Raised to Outperform at Baird. Bank of Ireland (NYSE:...
Published:
Last Updated:
Biotech and emerging pharma both seem to have almost no friends today despite a large stock market rally. It may take a resolution of the Genzyme Corporation (NASDAQ: GENZ) merger, and a successful...
Published: